OCT West Coast 2025: Patient and site centricity go hand-in-hand
By designing site-centric trials, sponsors can ensure their clinical trials also become patient-centric, said an expert at a conference. It…
By designing site-centric trials, sponsors can ensure their clinical trials also become patient-centric, said an expert at a conference. It…
China has seen a rise in ongoing clinical trials for the past few years which has now surpassed the US,…
Being realistic, responsive and transparent is key in engaging unresponsive and underperforming clinical trial sites; that was the takeaway from…
As President Trump’s tariff restrictions are imposed on China, the pharmaceutical industry has been deciphering how it will be impacted…
Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the company…
Novo Nordisk’s haemophilia A therapy Mim8 stopped bleeding completely in 74.3% of children in a Phase III trial. The FRONTIER3 trial…
A Sudan Ebola vaccine, provided by the International AIDS Vaccine Initiative (IAVI), is being investigated in a Uganda vaccine trial…
The removal of pages linking to diversity in clinical trials and healthcare is “disappointing”, according to pharma experts who believe…
Protocol deviations can be extremely costly to clinical trials - both financially and with patient safety. In some cases, they…
Small and medium-sized enterprises are always looking for ways to run effective trials at a reasonable cost. It has become…